No profile data available.
BioAge Labs, Inc. (BIOA) is a healthcare company in the obesity treatment pharmaceuticals industry, based in EmeryVille, United States, with about 60 full-time employees.
It reported revenue of $9.00 million for fiscal year 2025, and net income of -$80.61 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $2.77 million, up 91.0% from a year before. Its market capitalization was $290.99 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging.
BioAge Labs reported $9.00 million in revenue for fiscal year 2025. In Q1 2026 revenue was $2.77 million.
$290.99 million as of October 9, 2026.
Listed companies of a similar size in the same industry (obesity treatment pharmaceuticals) include Metsera, Inc. (MTSR), Rhythm Pharmaceuticals, Inc. (RYTM), Structure Therapeutics Inc. (GPCR), Aardvark Therapeutics, Inc. (AARD).